Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05530421 · RECRUITING
Trial details
- NCT number
- NCT05530421
- Sponsor
- University of Miami
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-26
- Primary completion
- 2028-03-26
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.